Cargando…

Outcomes of Window Therapy with Carboplatin and Ifosfamide for Pediatric Osteosarcoma: A Case Series

For the treatment of osteosarcoma, cisplatin (CDDP) can be substituted by carboplatin (CBDCA) to reduce toxicity. We report a single institution experience of CBDCA-based regimen. Two to three cycles of CBDCA + ifosfamide (IFO) therapy (window therapy) were administered as neoadjuvant therapy for os...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aiba, Hisaki, Kamei, Michi, Ito, Yasuhiko, Takeda, Risa, Yamada, Satoshi, Okamoto, Hideki, Hayashi, Katsuhiro, Miwa, Shinji, Kawaguchi, Yohei, Saito, Shiro, Sakai, Takao, Murakami, Hideki, Kimura, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136696/ https://www.ncbi.nlm.nih.gov/pubmed/37189985 http://dx.doi.org/10.3390/children10040736

Ejemplares similares

Efficacy of combination-chemotherapy with pirarubicin, ifosfamide, and etoposide for soft tissue sarcoma: a single-institution retrospective analysis
por: Saito, Shiro, et al.
Publicado: (2020)

Different patterns of pneumothorax in patients with soft tissue tumors treated with pazopanib: A case series analysis
por: Aiba, Hisaki, et al.
Publicado: (2021)

Local dissemination of osteosarcoma observed after massage therapy: a case report
por: Miwa, Shinji, et al.
Publicado: (2019)

Myelolipoma mimicking osteosarcoma in the distal femur
por: Sakai, Takao, et al.
Publicado: (2021)

Synchronous chondroblastomas in the knee joint: A case report
por: Sakai, Takao, et al.
Publicado: (2022)

Reverse lateral upper arm flaps for treating large soft tissue defects extending from the elbow to the forearm
por: Okamoto, Hideki, et al.
Publicado: (2022)

Treatment of a Malignant Soft Tissue Tumor Arising in the Vicinity of the Sciatic Nerve with an In-Situ Preparation Technique and Intensive Multidisciplinary Therapy
por: Aiba, Hisaki, et al.
Publicado: (2019)

Special Issue: “Pediatric Orthopedic Malignancy: Types, Symptoms, and Treatment”
por: Aiba, Hisaki, et al.
Publicado: (2023)

Osteosarcoma-Derived Small Extracellular Vesicles Enhance Tumor Metastasis and Suppress Osteoclastogenesis by miR-146a-5p
por: Araki, Yoshihiro, et al.
Publicado: (2021)

Bone Metastases from Gastric Cancer Resembling Paget’s Disease: A Case Report
por: Aiba, Hisaki, et al.
Publicado: (2022)

Impact of dexamethasone, etoposide, ifosfamide and carboplatin as concurrent chemoradiotherapy agents for nasal natural killer/T-cell lymphoma
por: HATAYAMA, YOSHIOMI, et al.
Publicado: (2013)

Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCL
por: Torka, Pallawi, et al.
Publicado: (2022)

Efficacy of perioperative chemotherapy for synovial sarcoma: a retrospective analysis of a Nationwide database in Japan
por: Xu, Gang, et al.
Publicado: (2021)

Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report
por: Sokolova, Alexandra, et al.
Publicado: (2017)

Treatment outcomes of T and natural‐killer/T‐cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy
por: Tay, Tricia, et al.
Publicado: (2022)

Clinical outcomes of radio‐hyperthermo‐chemotherapy for soft tissue sarcoma compared to a soft tissue sarcoma registry in Japan: a retrospective matched‐pair cohort study
por: Aiba, Hisaki, et al.
Publicado: (2018)

Retrospective Analysis of Bevacizumab in Combination with Ifosfamide, Carboplatin, and Etoposide in Patients with Second Recurrence of Glioblastoma
por: Arakawa, Yoshiki, et al.
Publicado: (2013)

Bortezomib, Ifosfamide, Carboplatin, and Etoposide in a Patient with HIV-Negative Relapsed Plasmablastic Lymphoma
por: Akce, Mehmet, et al.
Publicado: (2016)

Anti‐tumor effects of a nonsteroidal anti‐inflammatory drug zaltoprofen on chondrosarcoma via activating peroxisome proliferator‐activated receptor gamma and suppressing matrix metalloproteinase‐2 expression
por: Higuchi, Takashi, et al.
Publicado: (2018)

Preoperative evaluation of the efficacy of radio-hyperthermo-chemotherapy for soft tissue sarcoma in a case series
por: Aiba, Hisaki, et al.
Publicado: (2018)

Radiographic analysis of subclinical appearances of the hip joint among patients with labral tears
por: Aiba, Hisaki, et al.
Publicado: (2019)

Differences among the observers in the assessments of Japanese orthopedic association hip scores between surgeons and physical therapists and the correlations to patients’ reported outcomes after total hip arthroplasty
por: Aiba, Hisaki, et al.
Publicado: (2022)

Paclitaxel–ifosfamide–carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours
por: Kosmas, C, et al.
Publicado: (2011)

Gliosarcoma with Systemic Metastasis Showing Favorable Response to Ifosfamide, Carboplatin, and Etoposide Chemotherapy: An Autopsy Case Report
por: NAKAGAKI, Yuki, et al.
Publicado: (2022)

Evaluation of a method for calculating carboplatin dosage in DeVIC ± R therapy (combination therapy of dexamethasone, etoposide, ifosfamide and carboplatin with or without rituximab) as a salvage therapy in patients with relapsed or refractory non-Hodgkin lymphoma
por: Tomono, Ayana, et al.
Publicado: (2016)

A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma. The London Gynaecologic Oncology Group.
por: Perren, T. J., et al.
Publicado: (1993)

Efficacy and safety of ifosfamide-based chemotherapy for osteosarcoma: a meta-analysis
por: Fan, Xiao-Liang, et al.
Publicado: (2015)

Treatment of simple bone cysts using endoscopic curettage: a case series analysis
por: Aiba, Hisaki, et al.
Publicado: (2018)

Treatment of aneurysmal bone cysts using endoscopic curettage
por: Aiba, Hisaki, et al.
Publicado: (2018)

Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchus.
por: Thatcher, N., et al.
Publicado: (1989)

Ifosfamide, Cisplatin or Carboplatin, and Etoposide (ICE)-based Chemotherapy for Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Lymphomas
por: Zhou, Ping, et al.
Publicado: (2015)

Outcome and toxicity of ifosfamide, carboplatin, and etoposide versus gemcitabine and vinorelbine regimen for pediatric patients with relapsed or refractory Hodgkin’s lymphoma
por: Mahdy, Ahmed, et al.
Publicado: (2023)

Single‐Center Experience with Ifosfamide Monotherapy as Second‐Line Treatment of Recurrent/Metastatic Osteosarcoma
por: Verschoor, Arie Jan, et al.
Publicado: (2019)

Induced resistance to ifosfamide in osteosarcoma cells suggests a more aggressive tumor profile
por: de Oliveira Rodrigues, Maria Tereza, et al.
Publicado: (2022)

Current Concepts in the Resection of Bone Tumors Using a Patient-Specific Three-Dimensional Printed Cutting Guide
por: Aiba, Hisaki, et al.
Publicado: (2023)

Current and Emerging Targets in Immunotherapy for Osteosarcoma
por: Miwa, Shinji, et al.
Publicado: (2019)

Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first-relapse/primary refractory diffuse large B-cell lymphoma
por: Feldman, Tatyana, et al.
Publicado: (2014)

Comparison of Ifosfamide, Carboplatin and Etoposide versus Etoposide, Steroid, and Cytarabine Cisplatin as Salvage Chemotherapy in Patients with Refractory or Relapsed Hodgkin's lymphoma
por: Mehrzad, Valiollah, et al.
Publicado: (2017)

Response to ifosfamide, carboplatin, etoposide (ICE) vs. dexamethasone, cytarabine cisplatin (DHAP) as salvage chemotherapy in patients with relapsed/refractory lymphoma
por: Devi, Kanta, et al.
Publicado: (2023)

Ifosfamide-loaded lipid-core-nanocapsules to increase the anticancer efficacy in MG63 osteosarcoma cells
por: Wang, Sheng-Qun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ad2k65ihiihftj5vpnufpfagc9